In vitro HBV infection model using PHHs isolated from chimeric mice with human hepatocytes.
Susumu Hamada‐Tsutsumi(Nagoya City University), Tanaka Yasuhito, Kazuto Tajiri(Toyama University Hospital), Takashi Joh, Masanori Isogawa(Nagoya City University), Etsuko Iio(Nagoya City University), Takako Inoue(Kaneka (United States)), Tsunamasa Watanabe(St. Marianna University School of Medicine), Ozawa Tatsuhiko, Muraguchi Atsushi, Shuko Murakami(Nagoya City University), Sayuki Iijima(Nagoya City University), Kayoko Matsunami(Nagoya City University), Hiroyuki Kishi(University of Toyama)
Cited by 0
Related Papers
Gut Dysbiosis Associated With Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|187
A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection <i>in vitro</i>
|Proceedings of the National Academy of Sciences|2008|145
Hepatitis B virus and its sexually transmitted infection – an update
|Microbial Cell|2016|131
Novel biomarkers for the management of chronic hepatitis B
|Clinical and Molecular Hepatology|2020|128
Kupffer Cells Hasten Resolution of Liver Immunopathology in Mouse Models of Viral Hepatitis
|PLoS Pathogens|2011|116